---
title: "`WinKM`: Approximating win-loss probabilities"
subtitle: "Using overall and event-free survival functions"
css: wr_style.css
csl: apa.csl
author:
  name: Lu Mao
  affiliations: 
    - name: Department of Biostatistics & Medical Informatics
    - University of Wisconsin-Madison
    - Visit https://lmaowisc.github.io/winKM
format: 
  revealjs:
    theme: default
    auto-stretch: false
editor: visual
include-in-header:
  - text: |
      <style type="text/css">
      ul li ul li {
        font-size: 0.80em;
      }
      </style>
bibliography: references.bib
title-slide-attributes:
  data-background-image: images/LiDA-IG.bmp
  data-background-size: 15%
  data-background-position: 5% 5%
execute:
  eval: false
  echo: true
---

$$
\newcommand{\wh}{\widehat}
\newcommand{\wt}{\widetilde}
\def\bs{\boldsymbol}
\newcommand{\red}{}
\newcommand{\indep}{\perp \!\!\! \perp}
$$

## Outline

-   **Introduction**
-   **Methods**
    -   Win-loss estimands
    -   Approximating formula
    -   [`WinKM`](https://lmaowisc.github.io/winKM/) workflow
-   **Case studies**
    -   A colon cancer trial
    -   HF-ACTION trial
-   **Conclusion**

## Introduction

-   **Win-loss statistics**
    -   **Generalized pairwise comparisons** (GPC) [@buyse:2025]
    -   **Prioritization**: death \> nonfatal event (hospitalization/disease progression)
    -   **Proportions of wins vs losses**
        -   Win ratio [@pocock:2012], win odds [@brunner:2021], net benefit [@buyse:2010]
-   **Meta analysis?**
    -   Literature-wide evidence synthesis
    -   Earlier studies not reporting win-loss measures
    -   Patient-level data unavailable

<!-- ![](figs/pres_hf_reg.png){fig-align="center" width="55%"} -->

# Methods

## Notation

-   **Outcome data**
    -   $D_a$: Overall survival (OS) time
    -   $T_a$: Nonfatal event time
    -   $T_a^* = D_a\wedge T_a$: Event-free survival (EFS) time
    -   $a = 1$: treatment; 0: control
-   **Summary functions**
    -   **Joint survival**: $H_a(t, s)=\mathrm{pr}(T_a>t, D_a> s)$ - likely unavailable
    -   **OS**: $S_a(t) =\mathrm{pr}(D_a > t)$ - available through Kaplan-Meier (KM) curve
    -   **EFS**: $S_a^*(t) =\mathrm{pr}(T_a^* > t)$ - available through KM curve

## Win-Loss Estimands

-   **Win-loss probabilities** [@oakes:2016]\begin{align}
     w_{a, 1-a}(\tau) &= \mathrm{pr}(\mbox{Group $a$ wins by time $\tau$})\notag\\
     &=\mathrm{pr}\underbrace{(D_{1-a}<D_a\wedge \tau)}_{\mbox{Win on OS}} + 
     \mathrm{pr}\underbrace{(D_1\wedge D_0 >\tau, T_{1-a}<T_a\wedge \tau)}_{\mbox{Tie on OS,
     win on nonfatal}}\notag\\
     &= \int_0^\tau \color{blue}{S_a(t-)\mathrm{d} F_{1-a}(t)} 
     \quad\quad\quad\quad \big(F_a(t) = 1 - S_a(t)\big)\\
     &\hspace{1em}+\color{blue}{S_1(\tau)S_0(\tau)} \int_0^\tau \color{red}{\mathrm{pr}(T_a >t\mid D_a>\tau) \mathrm{pr}(t\leq T_{1-a} <t +\mathrm{d} t\mid D_{1-a}>\tau)}
    \end{align}
    -   **Win ratio**: $w_{1,0}(\tau)/w_{0,1}(\tau)$
    -   **Win odds**: $w_{1,0}(\tau)/w_{0,1}(\tau)$
    -   **Net benefit**: $w_{1,0}(\tau) - w_{0,1}(\tau)$

## Survival-Conditional Event Rate

-   **Second-term unknown** \begin{align}
    &\int_0^\tau \color{red}{\mathrm{pr}(T_a >t\mid D_a>\tau) \mathrm{pr}(t\leq T_{1-a} <t +\mathrm{d} t\mid D_{1-a}>\tau)}\\
    =& -\int_0^\tau \color{red}{H_a(t\mid \tau) H_{1-a}(\mathrm{d} t\mid \tau)}\\
    =&\,\color{red}{\mathrm{pr}(T_{1-a}<T_a\wedge \tau\mid D_1 > \tau, D_0 >\tau)}
    \end{align}
    -   $H_a(t\mid \tau)=\mathrm{pr}(T_a>t\mid D_a>\tau)$: event-free probabilities in $\tau$-survivors
    -   *Association* between death and nonfatal event
    -   Approximate it using $S_a(t), S^*_a(t)$, and component-specific event counts

## Approxmation - Idea

-   **Start with** $t$-survivors \begin{align}
    \mathrm{d}\Lambda_a(t\mid\tau) &:= \mathrm{pr}(t\le T_a < t + \mathrm{d} t\mid T_a\geq t, D_a>\color{red}{\tau})\\
    &\leq \mathrm{pr}(t\le T_a < t + \mathrm{d} t\mid T_a\geq t, D_a\geq \color{red}{t})\\
    &\approx \frac{N_a^{\rm E}}{N_a^*}\mathrm{d}\hat\Lambda_a^*(u)
    \end{align}
    -   Notation
        -   $N_a^{\rm E}$: number of nonfatal events
        -   $N_a^*$: number of composite (EFS) endpoints
        -   $\hat\Lambda_a^*(t)=-\log \hat S_a^*(t)$: cumulative hazard of EFS
    -   Inequality when *cross ratio* $\kappa(t, s)\geq 1$ (positive association)
    -   Make up for bias by approximating $\kappa(t, s)$

## Cross Ratio

-   **Local dependence** [@oakes:1982; @oakes:1986] \begin{align*}\label{eq:cr:def}
      \kappa_a(t, s) &=\frac{\mathrm{pr}(t\leq T_a< t +\mathrm{d} t\mid T_a\geq t,  D_a = s )}
    {\mathrm{pr}(t\leq T_a< t +\mathrm{d} t\mid T_a\geq t, D_a \geq s)}  \notag\\
    & = \frac{H_a(t, s)\partial^2 H_a(t, s)/(\partial t\partial s)}
    {\{\partial H_a(t, s)/\partial t\}\{\partial H_a(t, s)/\partial s\}}
    \end{align*}
    -   Relative change in nonfatal event risk at $t$ with death at $s$
-   **Under Gumbel--Hougaard copula** [@oakes:1989] $$
    \hat\kappa_a(t, s) \approx  1 + (\hat\theta_a - 1)\hat\Lambda_a^*(s)^{-1}
    $$
    -   $\hat\theta$: estimated association parameter

## Association Parameter

-   **Estimating association parameter** [@mao:2022] $$
    \hat\theta_a = \frac{\log(1-\hat r_a^{\rm E}/\hat r_a^*)}{\log(\hat r_a^{\rm D}/\hat r_a^*)}\vee 1
    $$
    -   $\hat r_a^{\rm E}=N_a^{\rm E}/L_a^*$: nonfatal event rate
    -   $\hat r_a^{\rm D}= N_a^{\rm D}/L_a^{\rm OS}$: death rate
    -   $\hat r_a^*= N^*/L_a^*$: composite event rate
    -   $L_a^{\rm OS}$: total person-time at risk for OS
    -   $L_a^*$: total person-time at risk for EFS

## Approxmation - Formula

-   **Formula** $$
    H_a(t\mid\tau) \approx \prod_{0\leq u \leq t}\left(1 - \frac{N_a^{\rm E}}{N_a^*}\mathrm{d}\hat\Lambda_a^*(u)\underbrace{\prod_{u\leq s \leq \tau}
       \left[1 - \{\hat\kappa_a(u, s)-1\}\frac{\mathrm{d}\hat F_a(s)}{\hat S_a(s)}\right]}_{\text{Bias correction for $\tau$-survivorship}}\right)
    $$

-   **Summary data needed**

    -   $\hat S_a(t)$, $\hat S_a^*(t)$: scan KM curves for OS and EFS ([WebPlotDigitizer](https://automeris.io/))
    -   $N_a^{\rm E}$, $N_a^{\rm D}$, $N_a^*$: event counts reported in paper or CONSORT diagram
    -   $L_a^{\rm OS}$, $L_a^*$: total follow-up times calculated from risk table

## `WinKM` Workflow

-   A **step-by-step** approach
    -   `prepare_km_data()`: read and clean digitized KM data
    -   `merge_endpoints()`: align OS and PFS on a common time grid
    -   `compute_increments()`: calculate $\mathrm{d}\hat S_a(t)$ and $\mathrm{d}\hat S^*_a(t)$
    -   `compute_followup()`: derive total follow-up times from at-risk tables
    -   `compute_theta()`: compute association parameters ($\theta_a$)
    -   `compute_win_loss()`: calculate final win/loss probabilities
-   An **all-in-one** approach using `run_win_loss_workflow()`
-   Visit [package website](https://lmaowisc.github.io/winKM/) for details

# Case Studies

## Colon Cancer Trial

\subsection{A colon cancer trial}

<!-- A landmark colon cancer trial reported by \cite{moertel:1990} evaluated the efficacy of levamisole and fluorouracil in 929 patients with stage C disease. -->

<!-- We consider a subset comparing the combined treatment (Lev+5FU; 304 patients) and the control (314 patients) on the hierarchical outcomes of death and relapse of cancer (nonfatal event). -->

<!-- To start, we generate the Kaplan--Meier (KM) curves for overall survival (OS) and  -->

<!-- relapse-free survival (RFS), as shown in Section~S3.1 of the supplementary material.  -->

<!-- Next, we use WebPlotDigitizer (\url{https://automeris.io/}), a free online plot-digitizing tool,  -->

<!-- to extract the estimates $\hat{S}_a(t)$ and $\hat{S}_a^*(t)$ from the graphs.  -->

<!-- These estimates are then used to reconstruct the KM curves in the left panel of Figure~\ref{fig:colon_recon_km}, with total event counts and person-years of follow-up  -->

<!-- obtained from the at-risk tables. The information in this panel forms the basis for -->

<!--  computing the win-loss probabilities. -->

<!-- The results are illustrated on the right panel. -->

<!-- The area plots show the estimates of $w_{1,0}(\tau)$ and $w_{0,1}(\tau)$ based on the -->

<!-- $\kappa$-adjusted approach of \eqref{eq:approx_spec}, where the darker color -->

<!-- represents win-loss determined on death and the lighter one represents win-loss -->

<!-- on relapse. {\red These estimates align remarkably well with the raw data-based -->

<!-- IPCW approach. On the other hand, the unadjusted lower bound in -->

<!-- \eqref{eq:np_bounds} leads to considerable overestimation of both win -->

<!-- and loss probabilities (due to overestimation of the risk of relapse).}  -->

<!-- The 1-, 2-, 4-, and 7-year win ratios by the adjusted approximation (IPCW) -->

<!-- are 1.71 (1.65), 1.47 (1.47), 1.53 (1.51), and 1.48 (1.51), respectively. -->

-   **Stage C disease** [@moertel:1990]
    -   Combined treatment (Lev+5FU; $n=304$) vs control ($n=314$ patients)
-   **KM curves** for OS and relapse-free survival (RFS)
    -   Extract estimates $\hat{S}_a(t)$ and $\hat{S}_a^*(t)$ from graphs using [WebPlotDigitizer](https://automeris.io/)
    -   Total event counts and person-years of follow-up from paper
-   **Compare estimates of** $w_{1,0}(\tau)$ and $w_{0,1}(\tau)$
    -   Adjusting for association between death and relapse (area plot)
    -   KM naive: without adjustment
    -   IPCW (reference): raw data-based estimates [@dong:2020; @parner:2024]

## Colon Cancer Trial: Results

-   **Left**: summary data; **right**: approximation results
    -   1-, 2-, 4-, and 7-year win ratios by the adjusted method (comparing with IPCW): 1.71 (1.65), 1.47 (1.47), 1.53 (1.51), and 1.48 (1.51), respectively

![](images/colon_recon_km.png){fig-align="center" width="75%"}

## HF-ACTION Trial

<!-- Over two thousand heart failure patients from North America and France participated in the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) between 2003 and 2007 \citep{oconner:2009}. The primary goal was to evaluate the effect of adding exercise training to usual care  on the composite endpoint of all-cause death or hospitalization (nonfatal event). We focus on a subgroup of 426 non-ischemic patients whose baseline cardiopulmonary exercise test lasted nine minutes or less. -->

<!-- We follow the same procedures as described in the previous example. -->

<!-- The raw data-based KM curves for OS and hospitalization-free survival (HFS) -->

<!-- are plotted in Section~S3.2 of the supplementary material. -->

<!-- The left panel of Figure~ shows the reconstructed curves along with summary data; -->

<!-- the right panel shows the corresponding win-loss estimates, -->

<!-- compared against the IPCW. -->

<!-- The 1-, 2-, 3-, and 4-year win ratios by the adjusted approximation (IPCW) -->

<!-- are 1.27 (1.23), 1.27 (1.29), 1.21 (1.21), and 1.21 (1.26), respectively. -->

-   **Study background** [@oconner:2009]
    -   2,000+ heart failure patients from North America and France
    -   Non-ischemic patients with baseline cardiopulmonary exercise test lasting 9 minutes or less (426 patients)
    -   Exercise training ($n=205$) vs usual care ($n=221$)
-   **KM curves** for OS and hospitalization-free survival (HFS)
    -   Extract estimates $\hat{S}_a(t)$ and $\hat{S}_a^*(t)$ from graphs using [WebPlotDigitizer](https://automeris.io/)
    -   Total event counts and person-years of follow-up from paper

## HF-ACTION Trial: Results

-   **Left**: summary data; **right**: approximation results
    -   1-, 2-, 3-, and 4-year win ratios by the adjusted method (comparing with IPCW): 1.27 (1.23), 1.27 (1.29), 1.21 (1.21), and 1.21 (1.26), respectively

![](images/hf_action_recon_km.png){fig-align="center" width="75%"}

# Conclusion

## Additional Resources

-   **Manuscript**

    > Mao, L. (2025+) Approximating Win-Loss Probabilities Based on the Overall and Event-Free Survival Functions. Available at [http://dx.doi.org/10.2139/ssrn.5142445](https://dx.doi.org/10.2139/ssrn.5142445)

-   **`WinKM` Website**

    > Calculating win-loss statistics using summary data: <https://lmaowisc.github.io/winkm/>

## Summary and Future Work

-   **`WinKM`**: approximating win-loss measures using published OS and EFS data
    -   Scanned KM curves
    -   Event counts (deaths, EFS endpoints, nonfatal events)
    -   Total follow-up times (from risk tables)
-   **Adding standard errors**
    -   Optimal combination of study-specific effect sizes
    -   Assessment of between-study heterogeneities

## References

::: {#refs}
:::
